Makale detayı · 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Dergi
Proc Natl Acad Sci U S AISSN 0027-8424
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
YÖKSİS
OpenAlex
Açık erişim · bronze
SJR Q1
JCR Q1
Atıf 63
Üst %10
Yüzdelik 95.4%
FWCI 3.95
- Yıl
- 2022
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı Proc Natl Acad Sci U S A
- Katalog eşleşmesi (ISSN) Proceedings of the National Academy of Sciences of the United States of America
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
63 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 63 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- Lymphoproliferation, Autoimmunity, and Recurrent Infections: Which Primary Immunodeficiency? 2023
- Natural history and genetic spectrum of the Turkish metaphyseal dysplasia cohort, including rare types caused by biallelic COL10A1, COL2A1, and LBR variants 2023
- Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination 2023